A partir de cette page vous pouvez :
Retourner au premier écran avec les dernières notices... |
Détail de l'auteur
Auteur Lawrence A. Lavery
Documents disponibles écrits par cet auteur
Ajouter le résultat dans votre panier Affiner la rechercheAll Feet on Deck: The Role of Podiatry During the COVID-19 Pandemic Preventing Hospitalizations in an Overburdened Health-Care System, Reducing Amputation and Death in People with Diabetes / Lee C. Rogers in Journal of the American Podiatric Medical Association, vol. 113, 02 (Mars 2023)
[article]
in Journal of the American Podiatric Medical Association > vol. 113, 02 (Mars 2023)
Titre : All Feet on Deck: The Role of Podiatry During the COVID-19 Pandemic Preventing Hospitalizations in an Overburdened Health-Care System, Reducing Amputation and Death in People with Diabetes Type de document : article de périodique Auteurs : Lee C. Rogers ; Lawrence A. Lavery ; Warren S. Joseph ; David G. Armstrong Année de publication : 2023 Langues : Anglais (eng) Descripteurs (mots clés) : [Thésaurus Mesh]Amputation chirurgicale
[Thésaurus Mesh]COVID-19
[Thésaurus Mesh]Hospitalisation
[Thésaurus Mesh]Pandémies
[Thésaurus Mesh]Pied diabétique
[Thésaurus Mesh]Podologie
[Thésaurus Mesh]Ulcère du piedRésumé : The coronavirus disease of 2019 pandemic is driving significant change in the health-care system and disrupting the best practices for diabetic limb preservation, leaving large numbers of patients without care. Patients with diabetes and foot ulcers are at increased risk for infections, hospitalization, amputations, and death. Podiatric care is associated with fewer diabetes-related amputations, emergency room visits, hospitalizations, length-of-stay, and costs. However, podiatrists must mobilize and adopt the new paradigm of shifts away from hospital care to community-based care. Implementing the proposed Pandemic Diabetic Foot Triage System, in-home visits, higher acuity office visits, telemedicine, and remote patient monitoring can help podiatrists manage patients while reducing the coronavirus disease of 2019 risk. The goal of podiatrists during the pandemic is to reduce the burden on the health-care system by keeping diabetic foot and wound patients safe, functional, and at home. Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité aucun exemplaire Are Surrogate Markers for Diabetic Foot Osteomyelitis Remission Reliable? / Peter A. Crisologo in Journal of the American Podiatric Medical Association, vol.111,05 (septembre-octobre 2021)
[article]
in Journal of the American Podiatric Medical Association > vol.111,05 (septembre-octobre 2021)
Titre : Are Surrogate Markers for Diabetic Foot Osteomyelitis Remission Reliable? Type de document : article de périodique Auteurs : Peter A. Crisologo ; Matthew Malone ; Javier La Fontaine ; Kavita Bhavan ; Adam Nichols ; Lawrence A. Lavery Année de publication : 0021 Langues : Anglais (eng) Descripteurs (mots clés) : [Thésaurus HELB]:Paramédical:Rémission
[Thésaurus Mesh]Infections des tissus mous
[Thésaurus Mesh]Marqueurs biologiques
[Thésaurus Mesh]Ostéomyélite
[Thésaurus Mesh]Pied diabétique
[Thésaurus Mesh]Revue de la littérature
[Thésaurus Mesh]Ulcère du piedRésumé : Background
We aimed to evaluate surrogate markers commonly used in the literature for diabetic foot osteomyelitis remission after initial treatment for diabetic foot infections (DFIs).
Methods
Thirty-five patients with DFIs were prospectively enrolled and followed for 12 months. Osteomyelitis was determined from bone culture and histologic analysis initially and for recurrence. Fisher exact and χ2 tests were used for dichotomous variables and Student t and Mann-Whitney U tests for continuous variables (α = .05).
Results
Twenty-four patients were diagnosed as having osteomyelitis and 11 as having soft-tissue infections. Four patients (16.7%) with osteomyelitis had reinfection based on bone biopsy. The success of osteomyelitis treatment varied based on the surrogate marker used to define remission: osteomyelitis infection (16.7%), failed wound healing (8.3%), reulceration (20.8%), readmission (16.7%), amputation (12.5%). There was no difference in outcomes among patients who were initially diagnosed as having osteomyelitis versus soft-tissue infections. There were no differences in osteomyelitis reinfection (16.7% versus 45.5%; P = .07), wounds that failed to heal (8.3% versus 9.1%; P = .94), reulceration (20.8% versus 27.3%; P = .67), readmission for DFIs at the same site (16.7% versus 36.4%; P = .20), amputation at the same site after discharge (12.5% versus 36.4%; P = .10). Osteomyelitis at the index site based on bone biopsy indicated that failed therapy was 16.7%. Indirect markers demonstrated a failure rate of 8.3% to 20.8%.
Conclusions
Most osteomyelitis markers were similar to markers in soft-tissue infection. Commonly reported surrogate markers were not shown to be specific to identify patients who failed osteomyelitis treatment compared with patients with soft-tissue infections. Given this, these surrogate markers are not reliable for use in practice to identify osteomyelitis treatment failure.Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité aucun exemplaire Are Surrogate Markers for Diabetic Foot Osteomyelitis Remission Reliable? / Peter A. Crisologo in Journal of the American Podiatric Medical Association, vol. 111, 05 (septembre-octobre 2021)
[article]
in Journal of the American Podiatric Medical Association > vol. 111, 05 (septembre-octobre 2021)
Titre : Are Surrogate Markers for Diabetic Foot Osteomyelitis Remission Reliable? Type de document : article de périodique Auteurs : Peter A. Crisologo ; Matthew Malone ; Javier La Fontaine ; Kavita Bhavan ; Adam Nichols ; Lawrence A. Lavery Année de publication : 2021 Langues : Anglais (eng) Descripteurs (mots clés) : [Thésaurus HELB]:Paramédical:Rémission
[Thésaurus Mesh]Marqueurs biologiques
[Thésaurus Mesh]Ostéomyélite
[Thésaurus Mesh]Pied diabétiqueRésumé : Background
We aimed to evaluate surrogate markers commonly used in the literature for diabetic foot osteomyelitis remission after initial treatment for diabetic foot infections (DFIs).
Methods
Thirty-five patients with DFIs were prospectively enrolled and followed for 12 months. Osteomyelitis was determined from bone culture and histologic analysis initially and for recurrence. Fisher exact and χ2 tests were used for dichotomous variables and Student t and Mann-Whitney U tests for continuous variables (α = .05).
Results
Twenty-four patients were diagnosed as having osteomyelitis and 11 as having soft-tissue infections. Four patients (16.7%) with osteomyelitis had reinfection based on bone biopsy. The success of osteomyelitis treatment varied based on the surrogate marker used to define remission: osteomyelitis infection (16.7%), failed wound healing (8.3%), reulceration (20.8%), readmission (16.7%), amputation (12.5%). There was no difference in outcomes among patients who were initially diagnosed as having osteomyelitis versus soft-tissue infections. There were no differences in osteomyelitis reinfection (16.7% versus 45.5%; P = .07), wounds that failed to heal (8.3% versus 9.1%; P = .94), reulceration (20.8% versus 27.3%; P = .67), readmission for DFIs at the same site (16.7% versus 36.4%; P = .20), amputation at the same site after discharge (12.5% versus 36.4%; P = .10). Osteomyelitis at the index site based on bone biopsy indicated that failed therapy was 16.7%. Indirect markers demonstrated a failure rate of 8.3% to 20.8%.
Conclusions
Most osteomyelitis markers were similar to markers in soft-tissue infection. Commonly reported surrogate markers were not shown to be specific to identify patients who failed osteomyelitis treatment compared with patients with soft-tissue infections. Given this, these surrogate markers are not reliable for use in practice to identify osteomyelitis treatment failure.Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité aucun exemplaire A Comparison of Pathogens in Skin and Soft-Tissue Infections and Pedal Osteomyelitis in Puncture Wound Injuries Affecting the Foot / David H. Truong in Journal of the American Podiatric Medical Association, vol. 112, 06 (Novembre 2022)
[article]
in Journal of the American Podiatric Medical Association > vol. 112, 06 (Novembre 2022)
Titre : A Comparison of Pathogens in Skin and Soft-Tissue Infections and Pedal Osteomyelitis in Puncture Wound Injuries Affecting the Foot Type de document : article de périodique Auteurs : David H. Truong ; Javier La Fontaine ; Matthew Malone ; Dane K. Wukich ; Kathryn E. Davis ; Lawrence A. Lavery Année de publication : 2022 Langues : Anglais (eng) Descripteurs (mots clés) : [Thésaurus Mesh]Étude comparative
[Thésaurus Mesh]Infection de plaie
[Thésaurus Mesh]Morsures et piqûres d'insectes
[Thésaurus Mesh]Pathogènes transmissibles par le sang
[Thésaurus Mesh]Pied diabétique
[Thésaurus Mesh]Ulcère du piedMots-clés : Infections de la peau et des tissus mous Résumé : Background: To compare pathogens involved in skin and soft-tissue infections (SSTIs) and pedal osteomyelitis (OM) in patients with and without diabetes with puncture wounds to the foot. Methods: We evaluated 113 consecutive patients between June 1, 2011, and March 31, 2019, with foot infection (SSTIs and OM) from a puncture injury sustained to the foot. Eighty-three patients had diabetes and 30 did not. We evaluated the bacterial pathogens in patients with SSTIs and pedal OM. Results: Polymicrobial infections were more common in patients with diabetes mellitus (83.1% versus 53.3%; P = .001). The most common pathogen for SSTIs and OM in patients with diabetes was Staphylococcus aureus (SSTIs, 50.7%; OM, 32.3%), whereas in patients without diabetes it was Pseudomonas (25%) for SSTIs. Anaerobes (9.4%) and fungal infection (3.1%) were uncommon. Pseudomonas aeruginosa was identified in only 5.8% of people with diabetes. Conclusions: The most common bacterial pathogen in both SSTIs and pedal OM was S aureus in patients with diabetes. Pseudomonas species was the most common pathogen in people without diabetes with SSTIs. Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité aucun exemplaire Does the start of dialysis initiate a period of increased risk of ulceration or amputation? / Lawrence A. Lavery in Journal of the American Podiatric Medical Association, vol. 108, 1 (Janvier-février 2018)
[article]
in Journal of the American Podiatric Medical Association > vol. 108, 1 (Janvier-février 2018) . - p. 1-5
Titre : Does the start of dialysis initiate a period of increased risk of ulceration or amputation? Type de document : article de périodique Auteurs : Lawrence A. Lavery, Auteur ; Ryan D. Lavery, Auteur Année de publication : 2018 Article en page(s) : p. 1-5 Langues : Anglais (eng) Descripteurs (mots clés) : [Thésaurus Mesh]Amputation chirurgicale
[Thésaurus Mesh]Diabète
[Thésaurus Mesh]Dialyse
[Thésaurus Mesh]Incidence
[Thésaurus Mesh]Pied diabétique
[Thésaurus Mesh]Ulcère du pied
[Thésaurus HELB]:Paramédical:Risques associés aux soinsMots-clés : dialysis amputation risk foot ulcer diabetic foot diabetes mellitus Résumé : Background: Dialysis therapy is associated with an increased incidence of lowerextremity wounds and amputations. We compared the incidence of foot ulcers and amputations before and after the start of dialysis. Methods: We evaluated 150 consecutive diabetic patients receiving dialysis and compared the incidence of foot complications 30 months before and after initiation of hemodialysis. We used claims data for diabetes, ulceration, and dialysis and abstracted medical records to verify diagnoses and dates of ulcers and amputations. We compared initial and cumulative ulcer/amputation incidence to account for multiple events in the same person over time. We used the same formula to determine the incidence rate difference and 95% confidence intervals (CIs) to compare new ulcers and amputations during the study. Results: There was no significant difference in the incidence of first foot ulcers before (91.7 per 1,000 patient-years; 95% CI, 73.7–112.3 per 1,000 patient-years) and after (82.7; 95% CI, 65.7–102.3) the start of hemodialysis. The incidence of cumulative ulcers was significantly higher before (304.0 per 1,000 patient-years; 95% CI, 270.8–340.2) compared with after (210.7 per 1,000 patient-years; 95% CI, 183.0–240.9) dialysis. There was no difference in the incidence of first amputation before (29.3 per 1,000 patient-years; 95% CI, 1 9.4–41.7 per 1,000 patient-years) and after (37.3 per 1,000 patient-years; 95% CI, 19.4–41.7 per 1,000 patient-years) dialysis or in the cumulative incidence of amputations before (61.3 per 1,000 patient-years; 95% CI, 46.7–8.4 per 1,000 patient-years) and after (58.7 per 1,000 patient-years; 95% CI, 44.5–75.5 per 1,000 patient-years) dialysis. Conclusions: There was no increase in the incidence of ulcers or amputations after beginning hemodialysis. Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité j Périodique Erasme - périodiques Périodiques Disponible J Périodique Erasme - périodiques Périodiques Disponible Effect of Sensory Neuropathy on the Predictive Value of Inflammatory Biomarkers for Osteomyelitis in Diabetic and Nondiabetic Patients with Foot Infections / Easton Ryan in Journal of the American Podiatric Medical Association, vol. 112, 02 (Avril-juin 2022)
PermalinkEvaluating pad in patients with diabetic charcot neuroarthropathy / Nicole Cates in Podiatry today, vol. 32, 1 (Janvier 2019)
PermalinkHigh-Risk Patients with Infected Puncture Wounds and Appropriate Tetanus Prophylaxis / David H. Truong in Journal of the American Podiatric Medical Association, vol. 113, 01 (Janvier 2023)
PermalinkIncidence and Recovery of Acute Kidney Injury in Diabetic and Nondiabetic Patients with Foot Infections / Easton Ryan in Journal of the American Podiatric Medical Association, vol. 112, 06 (Novembre 2022)
PermalinkIncidence of Complications and Risk Factors for Nonunion After Ankle Fracture in Diabetes Mellitus / Lawrence A. Lavery in Journal of the American Podiatric Medical Association, vol. 112, 05 (Septembre 2022)
PermalinkTemperature as a Causative Factor in Diabetic Foot Ulcers: A Call to Revisit Ulceration Pathomechanics / Metin Yavuz in Journal of the American Podiatric Medical Association, vol. 109, 05 (Septembre-décembre 2019)
Permalink